Silvia Marsoni

19.4k total citations · 5 hit papers
156 papers, 8.3k citations indexed

About

Silvia Marsoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Silvia Marsoni has authored 156 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 40 papers in Cancer Research. Recurrent topics in Silvia Marsoni's work include Colorectal Cancer Treatments and Studies (58 papers), Cancer Genomics and Diagnostics (31 papers) and Lung Cancer Treatments and Mutations (22 papers). Silvia Marsoni is often cited by papers focused on Colorectal Cancer Treatments and Studies (58 papers), Cancer Genomics and Diagnostics (31 papers) and Lung Cancer Treatments and Mutations (22 papers). Silvia Marsoni collaborates with scholars based in Italy, United States and Switzerland. Silvia Marsoni's co-authors include Alberto Bardelli, Salvatore Siena, Giulia Siravegna, Valter Torri, Andrea Sartore‐Bianchi, Roberto Labianca, Daniel J. Sargent, Stephen N. Thibodeau, Nathan R. Foster and Gianluca Mauri and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Silvia Marsoni

154 papers receiving 8.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrating liquid biopsies into the management of cancer

2017 1.4k citations Giulia Siravegna, Silvia Marsoni et al. profile →
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

2010 1.1k citations Daniel J. Sargent, Silvia Marsoni et al. Journal of Clinical Oncology profile →
Early‐onset colorectal cancer in young individuals

2018 409 citations Gianluca Mauri, Andrea Sartore‐Bianchi et al. profile →
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

2011 402 citations Nathan R. Foster, Stephen N. Thibodeau et al. JNCI Journal of the National Cancer Institute profile →
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

2013 376 citations Massimo Broggini, Roberto Labianca et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Marsoni Italy	42	4.8k	2.5k	2.5k	2.3k	2.2k	156	8.3k
Stefan Aebi Switzerland	38	4.2k 0.9×	1.9k 0.7×	3.1k 1.3×	2.3k 1.0×	1.2k 0.5×	141	7.8k
Gerald S. Falchook United States	50	5.4k 1.1×	1.5k 0.6×	2.5k 1.0×	5.2k 2.3×	2.6k 1.2×	390	10.6k
Elżbieta Senkus Poland	35	6.2k 1.3×	1.2k 0.5×	4.0k 1.6×	2.3k 1.0×	2.5k 1.2×	113	10.1k
Apostolia M. Tsimberidou United States	58	5.4k 1.1×	3.4k 1.4×	4.2k 1.7×	4.8k 2.1×	3.3k 1.5×	445	14.5k
Eduardo Díaz‐Rubio Spain	49	8.7k 1.8×	1.9k 0.8×	2.0k 0.8×	2.0k 0.9×	3.5k 1.6×	351	12.0k
Howard S. Höchster United States	56	8.1k 1.7×	2.0k 0.8×	1.8k 0.7×	2.4k 1.1×	3.3k 1.5×	342	12.0k
George Pentheroudakis Greece	43	4.5k 0.9×	1.7k 0.7×	1.3k 0.5×	1.6k 0.7×	1.5k 0.7×	228	7.6k
Philippe L. Bédard Canada	50	4.6k 1.0×	928 0.4×	2.9k 1.2×	3.2k 1.4×	2.3k 1.1×	347	9.7k
Sudhir Srivastava United States	41	3.6k 0.7×	3.3k 1.3×	2.7k 1.1×	3.4k 1.5×	1.5k 0.7×	142	8.9k
Massimo Gion Italy	30	3.8k 0.8×	835 0.3×	2.6k 1.1×	3.2k 1.4×	1.5k 0.7×	139	8.1k

Countries citing papers authored by Silvia Marsoni

Since Specialization

Citations

This map shows the geographic impact of Silvia Marsoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Marsoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Marsoni more than expected).

Fields of papers citing papers by Silvia Marsoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Marsoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Marsoni. The network helps show where Silvia Marsoni may publish in the future.

Co-authorship network of co-authors of Silvia Marsoni

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Marsoni. A scholar is included among the top collaborators of Silvia Marsoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Marsoni. Silvia Marsoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mauri, Gianluca, Giorgio Patelli, Andrea Sartore‐Bianchi, et al.. (2024). Early-onset cancers: Biological bases and clinical implications. Cell Reports Medicine. 5(9). 101737–101737. 18 indexed citations

Giannini, Valentina, Gianluca Mauri, Caterina Marchiò, et al.. (2024). Development And Validation Of An AI-Based Pathomics Biomarker To Predict Response To First-Line Treatment In Metastatic Colorectal Cancers.

Lonardi, Sara, Filippo Pietrantonio, Maria Giulia Zampino, et al.. (2023). LBA28 The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients. Annals of Oncology. 34. S1268–S1269. 32 indexed citations

Patelli, Giorgio, Gianluca Mauri, Federica Tosi, et al.. (2023). Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer. Clinical Cancer Research. 29(22). 4530–4539. 23 indexed citations

Leone, Alberto Giovanni, Raffaella Casolino, Dario Trapani, et al.. (2023). Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. EClinicalMedicine. 65. 102277–102277. 7 indexed citations

Berrino, Enrico, Emanuele Valtorta, Vito Amodio, et al.. (2023). Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features. Modern Pathology. 36(2). 100012–100012. 15 indexed citations

Amodio, Vito, Simona Lamba, Rosaria Chilà, et al.. (2022). Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance. Cancer Cell. 41(1). 196–209.e5. 24 indexed citations

Matafora, Vittoria, Umberto Restuccia, Simone Tamburri, et al.. (2020). Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity. EMBO Reports. 21(9). e50446–e50446. 33 indexed citations

Sartore‐Bianchi, Andrea, Federica Tosi, Francesca Bergamo, et al.. (2020). 507P Central nervous system recurrence in HER2-positive metastatic colorectal cancer. Annals of Oncology. 31. S455–S455. 2 indexed citations

10.

Corti, Giorgio, Alice Bartolini, Giovanni Crisafulli, et al.. (2019). A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology. Clinical Colorectal Cancer. 18(2). 91–101.e3. 19 indexed citations

11.

Siravegna, Giulia, Andrea Sartore‐Bianchi, Rebecca J. Nagy, et al.. (2019). Plasma HER2 ( ERBB2 ) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer. Clinical Cancer Research. 25(10). 3046–3053. 102 indexed citations

12.

Sartore‐Bianchi, Andrea, Silvia Marsoni, & Salvatore Siena. (2017). Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer. JAMA Oncology. 4(1). 19–19. 18 indexed citations

13.

Moreno, Víctor, David Olmos, Carlos Gomez‐Roca, et al.. (2014). Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study. Clinical Cancer Research. 20(22). 5663–5671. 14 indexed citations

14.

Migliardi, Giorgia, Francesco Sassi, Davide Torti, et al.. (2012). Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas. Clinical Cancer Research. 18(9). 2515–2525. 147 indexed citations

15.

Damia, Giovanna, Massimo Broggini, Silvia Marsoni, Sergio Venturini, & Daniele Generali. (2011). New Omics Information for Clinical Trial Utility in the Primary Setting. JNCI Monographs. 2011(43). 128–133. 2 indexed citations

16.

Sargent, Daniel J., Silvia Marsoni, Geneviève Monges, et al.. (2010). Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer. Journal of Clinical Oncology. 28(20). 3219–3226. 1114 indexed citations breakdown →

17.

Gallerani, Elisa, Jean Bauer, Dagmar Hess, et al.. (2010). A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies. Acta Oncologica. 50(7). 1105–1110. 11 indexed citations

18.

Mangioni, C., Giorgio Bolis, S. Pecorelli, et al.. (1989). Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin. JNCI Journal of the National Cancer Institute. 81(19). 1464–1471. 110 indexed citations

19.

Marsoni, Silvia, Daniel F. Hoth, Richard Simon, et al.. (1987). Clinical drug development: an analysis of phase II trials, 1970-1985.. PubMed. 71(1). 71–80. 63 indexed citations

20.

Liberati, A., Costantino Mangioni, Silvia Marsoni, et al.. (1985). Process and outcome of care for patients with ovarian cancer.. BMJ. 291(6501). 1007–1012. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact